COVID driven Omicron wave saw a surge in younger patients, deaths due to co-morbidities: ICMR
New Delhi: Indian Council of Medical Research chief Dr. Balram Bhargava stated that third COVID wave surge in India saw younger population as patients with lesser proportions of all symptoms and higher level of co-morbidities. Also, that 10 per cent of the deaths due to the Omicron variant had happened in vaccinated people who ended up in hospitals, as compared with 22 per cent in those who were not vaccinated against COVID.
About 91 percent of those vaccinated who died due to infection had co-morbidities, against 83 percent of those unvaccinated who succumbed to the infectious disease.
The mean age of the younger hospitalized population during this third wave was about 44 years, he said, but added that the incident of co-morbidities was higher in this group, at close to half (46 per cent).
According to the data collected of hospitalized people in 37 different hospitals across India which did the plasma study during the first and second surge and which are part of the National COVID Clinical Registry, the Omicron surge saw younger in-patients of 44 years as opposed to 55 years earlier, whereas a comparison of co-morbidities stood at 46 per cent versus the 66 per cent earlier. The study also found the common symptoms, mainly sore throat, lesser use of drugs, and significantly improved outcomes.
These results stressed that vaccines may be largely protecting people from severe COVID and deaths, said Dr. Bhargava.
The comparative study was conducted in two different time frame from November 15 to December 16, when Delta was the predominant variant and between December 16 to January 17, when Omicron variant was. These included 564 hospitalized due to Delta and 956 hospitalized due to Omicron.
Also Read:ICMR nominates Kerala Hospital as Advanced Centre for Clinical Trials
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.